| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 03/19/2008 | CN101146776A PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 03/19/2008 | CN101146769A Azolylacylguanidines as beta-secretase inhibitors |
| 03/19/2008 | CN100375742C 4-oxoquinoline compounds and its use |
| 03/18/2008 | USRE40156 Methods for repairing damaged intervertebral discs |
| 03/18/2008 | US7345175 Biphenyl derivatives |
| 03/18/2008 | US7345081 Azabicyclo-octane inhibitors of IAP |
| 03/18/2008 | US7345077 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4- (substituted cycloalkylmethyl) imidazol-2-ones and 4- (substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 03/18/2008 | US7345064 5-(4-pyridyl)valeric acid N-[2-(1-adamantyl)ethyl]-N-pentylamide; Autoimmune diseases such as rheumatoid arthritis, allergy and diabetes |
| 03/18/2008 | US7345060 E.g., biphenyl-2-ylcarbamic acid 1-{9-[2-(4-hydroxy-2-oxo-2,3-dihydrobenzothiazol-7-yl)ethylamino]nonyl}piperidin-4-yl ester;respiratory system disorders; bronchodilators; chronic obstructive pulmonary disease or asthma; affinity for dopamine D2 receptors; used with phosphodiesterase-4 inhibitor |
| 03/18/2008 | US7345052 Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| 03/18/2008 | US7345042 Piperazine derivatives; melanin concentrating hormone (MCH) receptor modulators; metabolic and/or eating disorders, diabetes |
| 03/18/2008 | US7344662 reverse synthetic strategy for making organic non-linear optical chromophores involves building up the chromophore from the electron-withdrawing end toward the electron-donating end |
| 03/18/2008 | CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 03/18/2008 | CA2206125C N-substituted hydrazinophenylsulphonylureas, as herbicides and plant growth regulators |
| 03/13/2008 | WO2008030520A1 Heterocyclic gpr40 modulators |
| 03/13/2008 | WO2008030448A1 Phenethylamide derivatives with kinase inhibitory activity |
| 03/13/2008 | WO2008030266A2 Insecticidal n-substituted (heteroaryl)alkyl sulfilmines |
| 03/13/2008 | WO2008029924A1 Cyclic aminoalkylcarboxamide derivative |
| 03/13/2008 | WO2008029825A1 Imidazole derivative |
| 03/13/2008 | WO2008028691A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 03/13/2008 | WO2008028624A1 Fungicides |
| 03/13/2008 | WO2008028590A1 Novel substituted bipyridine derivatives and their use as adenosine receptor ligands |
| 03/13/2008 | WO2008008718A3 Cyclopentane derivatives as antiglaucoma agents |
| 03/13/2008 | WO2007148185A3 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| 03/13/2008 | WO2007146838A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 03/13/2008 | WO2007146376A3 Substituted 3-cyanopyridines as protein kinase inhibitors |
| 03/13/2008 | WO2007136302A8 Active substances, pharmaceutical composition and a method for the production and use thereof |
| 03/13/2008 | WO2007135527A3 Benzimidazolyl compounds |
| 03/13/2008 | US20080064874 2-Halofuryl/Thienyl-3-Carboxamides |
| 03/13/2008 | US20080064740 Novel Thiophene Derivatives |
| 03/13/2008 | US20080064727 Crystalline forms of tiagabine hydrochloride |
| 03/13/2008 | US20080064726 Dipeptidyl peptidase-IV (DPP-IV) inhibitor; diabetes mellitus, insulin-resistant diseases, obesity, hypoglycemia ; 2-[4-({2-[(2S,4S)-2-cyano-4-fluoropyrrolidin-1-yl]-2-oxoethyl}amino)-4-methylpiperdin-1-yl]-2-oxoethyl acetate monofumarate |
| 03/13/2008 | US20080064695 Neuronal nicotinic acetylcholine receptor modulators; such as ethyl 1-[4-(aminosulfonyl)phenyl]-5-(4-bromophenyl)-2-methyl-1H-pyrrole-3-carboxylate |
| 03/13/2008 | US20080064690 Neuropathic or inflammatory pain relief; inhibiting ion flux through channel including PN3 subunit; potency |
| 03/13/2008 | US20080064684 Sub-type selective serotonin receptor agonists; antidepressants; schizophrenia, Alzheimer's Disease, Parkinson's Disease; alkylation or amidation of the heterocyclylbenzazole with an alkylhalide or acylhalide |
| 03/13/2008 | CA2662728A1 Substituted bipyridine derivatives and their use |
| 03/13/2008 | CA2662281A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators |
| 03/13/2008 | CA2662259A1 Fungicides |
| 03/13/2008 | CA2662112A1 Imidazole derivatives and their use as cannabinoid type 2 (cb2) receptor modulators |
| 03/13/2008 | CA2660757A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines |
| 03/12/2008 | EP1897881A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1897550A2 Prodrugs of Excitatory Amino Acids |
| 03/12/2008 | EP1896461A2 Bis-aryl kinase inhibitors and their use in the treatment of inflammation, angiogenesis and cancer |
| 03/12/2008 | EP1896456A2 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 03/12/2008 | EP1896454A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR -SECRETASE MODULATION |
| 03/12/2008 | EP1896448A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
| 03/12/2008 | EP1896422A2 Tyrosine kinase inhibitors |
| 03/12/2008 | EP1896421A2 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 03/12/2008 | EP1896417A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/12/2008 | EP1896014A2 Chemical compounds |
| 03/12/2008 | EP1656355B1 Piperazine derivatives and methods of use |
| 03/12/2008 | EP1581229B1 Phthalazine derivatives as phosphodiesterase 4 inhibitors |
| 03/12/2008 | EP1560815B1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 03/12/2008 | EP1534275B1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 03/12/2008 | CN101142285A Reactive azo dyes, methods for the production thereof and their use |
| 03/12/2008 | CN101142192A 1,2-diphenyl-imidazole derivatives and their use as CB1 receptor ligands |
| 03/12/2008 | CN101142184A Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 03/12/2008 | CN101139346A Benzimidazole-derivatives as factor Xa inhibitors |
| 03/12/2008 | CN100374425C Aryl and heteroaryl urea CHK1 inhibitors for use as radiosensitizers and chamosensitizers |
| 03/12/2008 | CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity |
| 03/11/2008 | US7342027 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 03/11/2008 | US7342020 Effective against MMP 9 and 13; arthritis, atherosclerosis; synthesis |
| 03/11/2008 | US7342019 5, 6-diaryl-pyrazine-2-amide derivatives as CB1 antagonists |
| 03/11/2008 | US7342015 Indole derivatives |
| 03/11/2008 | US7342013 Benzamides and related inhibitors of factor Xa |
| 03/11/2008 | US7342007 prevent the formation of neurological deposits of amyloid protein; Alzheimer's disease, cognitive impairment; novel lactarns; N2-[(3,5-difluorophenyl)acetyl]-N1-[(3S,7S)-1-methyl-2-oxo-7-phenyl-2,3,4,7-tetrahydro-1H-azepin-3-yl]-L-alaninamide; secretase inhibitors |
| 03/11/2008 | US7341759 Detector; immobilization of DNA; measuring current, voltage vartiations; immobilizing a probe to the surface of the electrically conductive polythiophene; contacting with sample to hybridize |
| 03/11/2008 | US7341700 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching |
| 03/11/2008 | CA2485298C Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/11/2008 | CA2340230C Pyridazinone derivatives having cell adhesion inhibiting activity |
| 03/11/2008 | CA2293382C Piperazine derivatives and their use as anti-inflammatory agents |
| 03/11/2008 | CA2223535C 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 03/06/2008 | WO2008028118A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators |
| 03/06/2008 | WO2008027542A2 5-substituted isoindoline compounds |
| 03/06/2008 | WO2008026704A1 Isoquinoline derivative |
| 03/06/2008 | WO2008025886A1 Metal chelates and chelating agents containing triazolyl subunits |
| 03/06/2008 | WO2008025820A1 Aminopyridine derivates as kinase inhibitors |
| 03/06/2008 | WO2007149829A3 Therapeutic compounds |
| 03/06/2008 | WO2007146225A3 Heterocyclic aspartyl protease inhibitors |
| 03/06/2008 | WO2007143506A3 Substituted benzimidazole thiophene benzyl ether compounds |
| 03/06/2008 | WO2007133622A3 Selective inhibitors of rock protein kinase and uses thereof |
| 03/06/2008 | WO2007131201A3 Compounds and compositions as hedgehog pathway modulators |
| 03/06/2008 | WO2007117607A9 Quinazolines for pdk1 inhibition |
| 03/06/2008 | US20080058384 Novel Compounds |
| 03/06/2008 | US20080058382 Polyamine compounds |
| 03/06/2008 | US20080058372 2,5-bis{[alkyl(or aryl)imino]aminophenyl}furans and thiophenes; "reversed" amidines; DNA-binding affinities; microbiocide; mycobacterial, fungal, protozoal infection; Mycobacterium tuberculosis, Trypanosoma spp., Candida albicans, Aspergillus spp., Cryptosporidium parvum, Giardia lamblia, Plasmodium spp. |
| 03/06/2008 | US20080058356 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists |
| 03/06/2008 | US20080058334 Dermatological or oncological disorders; N-(4-fluorophenyl)-N'-[4-[1-(1H-imidazol-1-yl)-2-methylpropyl]phenyl]urea for example |
| 03/06/2008 | US20080058332 Antiproliferative, antitumor agents; 4-(3-hydroxyphenyl)-6-morpholino-2-(3-piperidin-4-ylcarbonylaminophenyl)pyrimidine for example |
| 03/06/2008 | US20080058324 Alpha-Keto Carbonyl Calpain Inhibitors |
| 03/06/2008 | US20080058319 Fused ring heterocycles as potassium channel modulators |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | CA2662274A1 Chemical compounds |
| 03/06/2008 | CA2660806A1 5-substituted isoindoline compounds |
| 03/05/2008 | EP1893605A2 Saminopyrimidine derivates with tie2 inhibiting activity |
| 03/05/2008 | EP1893597A2 Ampa receptor potentiators |
| 03/05/2008 | EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 03/05/2008 | EP1893577A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/05/2008 | EP1893576A1 Treatment of protein folding disorders |